Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Volume:8 Issue:9 Number:19 ISSN#:2563-5476
Author Verified
ACE Report #12327
Ace Report Cover General Orthopaedics

Addition of Rifampin to Antimicrobial Therapy Does Not Improve Success Rate in Staphylococcal PJI

Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1

Rifampin combination therapy in staphylococcal prosthetic joint infections: a randomized controlled trial.

J Orthop Surg Res. 2020; 15: 365.

Contributing Authors: OE Karlsen P Borgen B Bragnes W Figved B Grogaard J Rydinge L Sandberg F Snorrason H Wangen E Witsoe M Westberg

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here


Sixty-five patients with staphylococcal peri-prosthetic joint infections of the hip or knee were randomized to receive debridement and wound excision plus 6 weeks of antimicrobial therapy (intravenous cloxacillin or vancomycin), with or without the addition of oral rifampin. The outcome of interest was treatment success at 2 years follow up, defined as a lack of clinical signs of peri-prosthetic j...

To view the full report, start your 30-day free trial today

No credit card required

JOIN Forgot Password?

Not sure if you want to join OrthoEvidence?

Access this report without an Account.

Success, an email containing a link to access this report has been sent to your inbox.

CME Image

Continuing Medical Education Credits

You could be earning 0.5 CME credits for each report you read.


Please Login or Join to leave comments.